Fred Waldman

Quest Diagnostics (United States) — United States

Biochemistry, Genetics and Molecular Biology · Life Sciences

26h-index7.3kcitations53works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Genomics and Diagnostics(16), Genomic variations and chromosomal abnormalities(15), Bladder and Urothelial Cancer Treatments(13), Genetic factors in colorectal cancer(8), Breast Cancer Treatment Studies(5)

Publications53 total

Novel neoadjuvant therapy paradigms for bladder cancer: Results from the National Cancer Center Institute Forum
Urologic Oncology Seminars and Original Investigations·2014· 24 cited
An optimized five-gene multi-platform predictor of hormone receptor negative and triple negative breast cancer metastatic risk
Breast Cancer Research·2013· 36 citedOpen Access
Genomic aberrations in normal tissue adjacent to HER2-amplified breast cancers: field cancerization or contaminating tumor cells?
Breast Cancer Research and Treatment·2012· 15 citedOpen Access
Genomic copy number alterations in clear cell renal carcinoma: associations with case characteristics and mechanisms of VHL gene inactivation
Oncogenesis·2012· 71 citedOpen Access
A multigene predictor of metastatic outcome in early stage hormone receptor-negative and triple-negative breast cancer
Breast Cancer Research·2010· 203 citedOpen Access
Abstract 2198: Exome and transcriptome sequencing of human tumors and tumor-derived cell lines
Cancer Research·2010
Predictive models in external beam radiotherapy for clinically localized prostate cancer
Cancer·2009· 58 citedOpen Access
Risk estimation of distant metastasis in node-negative, estrogen receptor-positive breast cancer patients using an RT-PCR based prognostic expression signature
BMC Cancer·2008· 57 citedOpen Access
A qRT-PCR GENE SIGNATURE THAT PREDICTS LYMPH NODE STATUS IN HIGH RISK PROSTATE CANCER PATIENTS
The Journal of Urology·2008
The prognostic role of the human embryonic stem cell protein, NANOG, in breast cancer
Fertility and Sterility·2007· 1 cited
Use of Von-Hippel Lindau (VHL) mutation status to predict objective response to vascular endothelial growth factor (VEGF) -targeted therapy in metastatic renal cell carcinoma (RCC)
Journal of Clinical Oncology·2007· 28 cited
An RT-PCR-based multi-gene prognostic signature predicts distant metastasis of node negative, ER positive breast cancer from FFPE sections
Journal of Clinical Oncology·2006· 1 cited
Bladder Cancer Outcome and Subtype Classification by Gene Expression
The Journal of Urology·2006· 26 cited
Bladder Cancer Stage and Outcome by Array-Based Comparative Genomic Hybridization
The Journal of Urology·2006· 16 cited
Genomic and transcriptional events associated with poor clinical responses to conventional therapies
Breast Cancer Research·2005Open Access
Concepts for Banking Tissue in Urologic Oncology—The International Bladder Cancer Bank
Clinical Cancer Research·2005· 13 citedOpen Access
The International Bladder Cancer Bank: Proposal for a new study concept
Urologic Oncology Seminars and Original Investigations·2004· 23 cited
Prognostic relevance of 20q13 gains in sporadic colorectal cancers: a FISH analysis
Scandinavian Journal of Gastroenterology·2004· 55 cited
The comparative genetics and genomics of cancer: of mice and men
Breast Cancer Research·2003Open Access
The APC/beta-catenin pathway in ulcerative colitis-related colorectal cancers A mutational analysis
Proceedings of the American Association for Cancer Research Annual Meeting·2001
page 1 of 3Next →

Frequent Co-authors

Joe W. Gray(12), Karen Chew(12), Anne Kallioniemi(11), Olli Kallioniemi(11), Helene S. Smith(7), Guido Sauter(7), D. Pinkel(6), Daniel Pinkel(5), William H. Goodson(5), Brian H. Mayall(5), Laura J. Esserman(4), John J. Sninsky(4), Christopher C. Benz(4), Holger Moch(4), Michael J. Mihatsch(4), Damir Sudar(3), Dan Pinkel(3), Barbara J. Trask(3), Jeff Simko(3), Britt‐Marie Ljung(3)